Evaluation of clinical risk factors for developing pleural empyema secondary to liver abscess

Abstract Background The aim of this study was to investigate the clinical manifestation and predictive risk factors of pleural empyema developing during treatment of the pyogenic liver abscess. Methods Medical records of patients with the liver abscess in our institution were reviewed retrospectivel...

Full description

Bibliographic Details
Main Authors: Eunjue Yi, Tae Hyung Kim, Jun Hee Lee, Jae Ho Chung, Sungho Lee
Format: Article
Language:English
Published: BMC 2019-12-01
Series:BMC Gastroenterology
Subjects:
Online Access:https://doi.org/10.1186/s12876-019-1128-4
id doaj-27f219cd76774097af98d7b0fbba617c
record_format Article
spelling doaj-27f219cd76774097af98d7b0fbba617c2020-12-20T12:13:40ZengBMCBMC Gastroenterology1471-230X2019-12-0119111010.1186/s12876-019-1128-4Evaluation of clinical risk factors for developing pleural empyema secondary to liver abscessEunjue Yi0Tae Hyung Kim1Jun Hee Lee2Jae Ho Chung3Sungho Lee4Department of Thoracic and Cardiovascular Surgery, Korea University College of MedicineDepartment of Internal Medicine, Korea University College of MedicineDepartment of Thoracic and Cardiovascular Surgery, Korea University College of MedicineDepartment of Thoracic and Cardiovascular Surgery, Korea University College of MedicineDepartment of Thoracic and Cardiovascular Surgery, Korea University College of MedicineAbstract Background The aim of this study was to investigate the clinical manifestation and predictive risk factors of pleural empyema developing during treatment of the pyogenic liver abscess. Methods Medical records of patients with the liver abscess in our institution were reviewed retrospectively. Enrolled patients were classified into four groups; Group 1: patients without pleural effusion, Group 2: patients with pleural effusion and who were treated noninvasively, Group 3: patient with pleural effusion and who were treated with thoracentesis, and Group 4: patients with pleural effusion that developed into empyema. Patient characteristics, clinical manifestation, and possible risk factors in development of empyema were analyzed. Results A total of 234 patients was enrolled in this study. The incidence rate of empyema was 4.27% (10 patients). The mean interval for developing pleural effusion was 5.6 ± 6.35 days. In multivariate analysis, risk factors for developing pleural effusion included the location of the liver abscess near the right diaphragm (segment 7 and 8, OR = 2.30, p = 0.048), and larger diameter of the liver abscess (OR = 1.02, p = 0.042). Among patients who developed pleural effusions, presences of mixed microorganisms from culture of liver aspirates (OR = 10.62, p = 0.044), bilateral pleural effusion (OR = 46.72, p = 0.012) and combined biliary tract inflammation (OR = 21.05, p = 0.040) were significantly associated with the need for invasive intervention including surgery on effusion. Conclusion The location of the liver abscess as well as pleural effusion, elevated inflammatory markers, and combined biliary tract inflammation may be important markers of developing pleural complication in patients with pyogenic liver abscess.https://doi.org/10.1186/s12876-019-1128-4Liver abscessPleural empyemaRisk factors
collection DOAJ
language English
format Article
sources DOAJ
author Eunjue Yi
Tae Hyung Kim
Jun Hee Lee
Jae Ho Chung
Sungho Lee
spellingShingle Eunjue Yi
Tae Hyung Kim
Jun Hee Lee
Jae Ho Chung
Sungho Lee
Evaluation of clinical risk factors for developing pleural empyema secondary to liver abscess
BMC Gastroenterology
Liver abscess
Pleural empyema
Risk factors
author_facet Eunjue Yi
Tae Hyung Kim
Jun Hee Lee
Jae Ho Chung
Sungho Lee
author_sort Eunjue Yi
title Evaluation of clinical risk factors for developing pleural empyema secondary to liver abscess
title_short Evaluation of clinical risk factors for developing pleural empyema secondary to liver abscess
title_full Evaluation of clinical risk factors for developing pleural empyema secondary to liver abscess
title_fullStr Evaluation of clinical risk factors for developing pleural empyema secondary to liver abscess
title_full_unstemmed Evaluation of clinical risk factors for developing pleural empyema secondary to liver abscess
title_sort evaluation of clinical risk factors for developing pleural empyema secondary to liver abscess
publisher BMC
series BMC Gastroenterology
issn 1471-230X
publishDate 2019-12-01
description Abstract Background The aim of this study was to investigate the clinical manifestation and predictive risk factors of pleural empyema developing during treatment of the pyogenic liver abscess. Methods Medical records of patients with the liver abscess in our institution were reviewed retrospectively. Enrolled patients were classified into four groups; Group 1: patients without pleural effusion, Group 2: patients with pleural effusion and who were treated noninvasively, Group 3: patient with pleural effusion and who were treated with thoracentesis, and Group 4: patients with pleural effusion that developed into empyema. Patient characteristics, clinical manifestation, and possible risk factors in development of empyema were analyzed. Results A total of 234 patients was enrolled in this study. The incidence rate of empyema was 4.27% (10 patients). The mean interval for developing pleural effusion was 5.6 ± 6.35 days. In multivariate analysis, risk factors for developing pleural effusion included the location of the liver abscess near the right diaphragm (segment 7 and 8, OR = 2.30, p = 0.048), and larger diameter of the liver abscess (OR = 1.02, p = 0.042). Among patients who developed pleural effusions, presences of mixed microorganisms from culture of liver aspirates (OR = 10.62, p = 0.044), bilateral pleural effusion (OR = 46.72, p = 0.012) and combined biliary tract inflammation (OR = 21.05, p = 0.040) were significantly associated with the need for invasive intervention including surgery on effusion. Conclusion The location of the liver abscess as well as pleural effusion, elevated inflammatory markers, and combined biliary tract inflammation may be important markers of developing pleural complication in patients with pyogenic liver abscess.
topic Liver abscess
Pleural empyema
Risk factors
url https://doi.org/10.1186/s12876-019-1128-4
work_keys_str_mv AT eunjueyi evaluationofclinicalriskfactorsfordevelopingpleuralempyemasecondarytoliverabscess
AT taehyungkim evaluationofclinicalriskfactorsfordevelopingpleuralempyemasecondarytoliverabscess
AT junheelee evaluationofclinicalriskfactorsfordevelopingpleuralempyemasecondarytoliverabscess
AT jaehochung evaluationofclinicalriskfactorsfordevelopingpleuralempyemasecondarytoliverabscess
AT sungholee evaluationofclinicalriskfactorsfordevelopingpleuralempyemasecondarytoliverabscess
_version_ 1724376912863690752